» Articles » PMID: 27513848

Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images After More Than 35 Administrations of Linear Gadolinium-based Contrast Agents

Overview
Journal Radiology
Specialty Radiology
Date 2016 Aug 12
PMID 27513848
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose To explore the extent of signal hyperintensity in the brain on unenhanced T1-weighted magnetic resonance (MR) images with increasing gadolinium-based contrast agent (GBCA) doses in patients who received 35 or more linear GBCA administrations. Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective study, picture archiving and communication systems of two tertiary referral hospitals were searched to identify patients who received 35 or more linear GBCA administrations. Unenhanced T1-weighted images of the brain in patients after six, 12, and 24 GBCA administrations and after the final GBCA administration were independently reviewed by three radiologists to identify sites where T1 signal intensity was increasing. Areas identified by all three observers as increasing in T1 signal intensity when compared with baseline images were further analyzed with a quantitative region of interest analysis measuring the rate of signal increase per injection and the total change after 24 linear GBCA administrations relative to reference tissues that did not show T1 shortening. Results Qualitative analysis of 13 patients with 39-59 linear GBCA administrations showed visually detectable T1 shortening in the dentate nucleus (n = 13), globus pallidus (n = 13), substantia nigra (n = 13), posterior thalamus (n = 12), red nucleus (n = 10), colliculi (n = 10), superior cerebellar peduncle (n = 7), caudate nucleus (n = 4), whole thalamus (n = 3), and putamen (n = 2). Quantitative analysis enable confirmation of signal intensity increases on unenhanced T1-weighted images relative to reference tissues in the dentate nucleus (0.53% signal intensity increase per injection, P < .001), globus pallidus (0.23% increase, P = .009), posterior thalamus (0.26% increase, P < .001), substantia nigra (0.25% increase, P = .01), red nucleus (0.25% increase, P = .01), cerebellar peduncle (0.19% increase, P = .001), and colliculi (0.21% increase, P = .02). Conclusion Increased signal intensity on unenhanced T1-weighted images was seen in the posterior thalamus, substantia nigra, red nucleus, cerebellar peduncle, colliculi, dentate nucleus, and globus pallidus. RSNA, 2016.

Citing Articles

Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.

Hummel L, Frenzel T, Boyken J, Pietsch H, Seeliger E Invest Radiol. 2023; 59(2):150-164.

PMID: 38157437 PMC: 11441738. DOI: 10.1097/RLI.0000000000001054.


Effect of body mass index (BMI) on image contrast in the hepatobiliary phase of Gd-EOB-DTPA-enhanced-MRI and the feasibility of the application of half-dose Gd-EOB-DTPA to hepatobiliary phase imaging in patients with a BMI less than 24: a....

Chen R, Lu Y, Xiao Z, Zhang Z, Lv F, Lv F Quant Imaging Med Surg. 2023; 13(9):6176-6192.

PMID: 37711824 PMC: 10498238. DOI: 10.21037/qims-23-653.


Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS.

Mohammadzadeh M, Kolahi S, Mehrabi Nejad M, Firouznia K, Naghibi H, Mohammadzadeh A AJNR Am J Neuroradiol. 2022; 43(10):1403-1410.

PMID: 36574329 PMC: 9575534. DOI: 10.3174/ajnr.A7623.


Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.

Nakamura K, McGinley M, Jones S, Lowe M, Cohen J, Ruggieri P J Neuroimaging. 2022; 33(1):85-93.

PMID: 36181666 PMC: 9847209. DOI: 10.1111/jon.13057.


Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review.

Al-Muhanna A Saudi J Med Med Sci. 2022; 10(1):12-18.

PMID: 35283709 PMC: 8869263. DOI: 10.4103/sjmms.sjmms_198_21.